(Q36381168)

English

Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway

scientific article

Statements

Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit